Real-world clinical effectiveness on glycaemic parameters, safety and additional benefits of Glargine U300 (Toujeo®) initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus
Background: Several studies have proved the advantages of second-generation insulin analogs in lowering intra-individual variability in plasma insulin levels, flexibility in dosing, a sustained glucose-lowering effect, and decreasing the risk of hypoglycemia. Glargine 300 is one of the newer second-...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| মালা: | Indian Journal of Endocrinology and Metabolism |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | http://www.ijem.in/article.asp?issn=2230-8210;year=2023;volume=27;issue=5;spage=426;epage=430;aulast=Shah |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|